市場調查報告書

全球微流體單元市場預測

Global Microfluidics Devices Market Research Report Forecast To 2024

出版商 Market Research Future 商品編碼 581853
出版日期 內容資訊 英文 86 Pages
訂單完成後即時交付
價格
全球微流體單元市場預測 Global Microfluidics Devices Market Research Report Forecast To 2024
出版日期: 2017年04月23日內容資訊: 英文 86 Pages
簡介

本報告提供全球微流體單元市場相關調查分析,市場動態,市場要素分析,各市場區隔的市場分析,競爭情形,主要企業等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 市場動態

  • 簡介
  • 促進因素
  • 阻礙因素
  • 機會

第4章 市場要素分析

  • 波特的五力分析
  • 主要企業的競爭定位與市場佔有率分析

第5章 全球微流體素子市場:各產業

  • 體外診斷 (IVD)
  • 醫藥品
  • 醫療設備

第6章 全球微流體素子市場:各材料

  • 聚合物
  • 玻璃

第7章 全球微流體素子市場:各用途

  • 醫藥品、生命科學研究
  • 臨床、獸醫用診斷
  • 照護現場 (POC)
  • 分析設備
  • 藥物輸送
  • 環境、工業用途

第8章 全球微流體素子市場:各地區

  • 北美
  • 歐洲
  • 亞洲

第9章 全球微流體素子市場:企業簡介

  • F. HOFFMANN-LA ROCHE AG
  • ABBOTT LABORATORIES
  • SIEMENS HEALTHCARE GMBH
  • AGILENT TECHNOLOGIES, INC
  • FLUIDIGM CORPORATION
  • BIO-RAD LABORATORIES, INC.
  • CEPHEID
  • RAINDANCE TECHNOLOGIES, INC
  • DOLOMITE CENTRE
  • MICRONIT MICROFLUIDICS
  • JOHNSON & JOHNSON
  • BECTON, DICKINSON AND COMPANY

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Globally, the market for microfluidic devices is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, and increasing point of care testing demand.

The total microfluidic devices market is expected to reach USD 13,244.5 million by 2024 at a CAGR of 19.7% during the forecasted period.

The global microfluidic devices market is segmented on the basis of industry, materials and applications. Microfluidic devices market has been segmented on the basis of industry which comprises of in-vitro diagnostics, pharmaceutical, medical devices. In-Vitro diagnostics segment accounted for the largest market share registering USD 1,079.7 million in 2015 and expected to reach at USD 6,575.6 million by 2024 at the CAGR of 19.5% from 2016-2024

On the materials, market is segmented into polymer, glass, silicon. Of which, glass is the fastest growing segment globally, and is expected to grow at a CAGR of 21.0% during forecasted period

On the basis of application, market is segmented into clinical and veterinary diagnostics, point of care, analytical devices, drug delivery, environmental and industrial applications. Pharmaceutical and life science research segment commands maximum share of microfluidic devices market in 2015 registering USD 527.4 million in the same years and is expected to reach USD 2,924.9 million in 2024

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America accounted for the largest market share of global microfluidic devices market, registering USD 969.2 million in 2015 and expected to reach at USD 4,885.7 million by 2024. Asia-Pacific is the fastest growing market and is expected to grow at a CAGR of 22.6% during forecasted period

Key Players

The leading market players in the global microfluidics devices market include Abbott, Agilent technologies, Inc, Bio-Rad Laboratories, Inc., Cepheid, Dolomite Centre, F. Hoffmann-La Roche AG, Fluidigm Corporation, Micronit microfluidics, Raindance Technologies, Inc, Siemens Healthcare GmbH and others.

Study objectives

  • To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global microfluidics devices market
  • To provide insights about factors influencing and affecting the market growth
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
  • To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global microfluidics devices market.
  • To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors that influences the global microfluidics devices market
  • To provide detailed analysis of the value chain and supply chain of the global microfluidics devices market

Target Audience

  • Pharmaceutical Companies
  • Pharmaceutical Suppliers
  • Potential investors
  • Key executive (CEO and COO) and strategy growth manager
  • Reaserch companies

Key Findings

  • The Microfluidic devices global market and is expected to reach USD 13.24 million by 2024
  • In-vitro diagnostics industry holds the largest share of 50.6% of the market.
  • North America holds the largest market share of 45.4% of microfluidic devices market and is anticipated to reach USD 4,885.70 million by the end of forecast period
  • Asia the fastest growing region and expected to grow at the CAGR of 22.90% during the forecast period

The reports also covers regional analysis

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Republic of Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa

Table of Contents

Table of Contents:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

3 MARKET DYNAMICS

3.1 INTRODUCTION

3.2 DRIVERS

3.2.1 MATERIAL MIX CHANGES PROVIDING OPPORTUNITIES FOR NEW PLAYERS

3.2.2 INCREASE IN GLOBAL DEMAND FOR POINT OF CARE TESTING

3.2.3 MICROFLUIDIC TECHNOLOGIES FOR MINIATURIZATION OF CHIP

3.2.4 RISING DEMAND IN GENOMICS AND PROTEOMICS STUDIES

3.3 RESTRAINTS

3.3.1 GEOMETRICAL AND SURFACE CHEMISTRY ISSUES

3.3.2 ADHERENCE TO STRINGENT REGULATORY REQUIREMENTS

3.4 OPPORTUNITIES

3.4.1 NEW PRODUCT INNOVATIONS

3.4.2 RISE IN PARTNERSHIPS AND COLLABORATIONS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

4.7 COMPETITIVE POSITIONING OF KEY COMPETITORS AND MARKET SHARE ANALYSIS

5 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY

5.1 IN-VITRO DIAGNOSTICS (IVD)

5.2 PHARMACEUTICAL

5.3 MEDICAL DEVICES

6 GLOBAL MICROFLUIDIC DEVICES MARKET, BY MATERIAL

6.1 POLYMER

6.2 GLASS

6.3 SILICON

7 GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION

7.1 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH

7.2 CLINICAL AND VETERINARY DISGNOSTICS

7.3 POINT OF CARE

7.4 ANALYTICAL DEVICES

7.5 DRUG DELIVERY

7.6 ENVIRONMENTAL AND INDUSTRIAL APPLICATIONS

8 GLOBAL MICROFLUIDIC DEVICES MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA

8.3.1 INTRODUCTION

9 GLOBAL MICROFLUIDIC DEVICES MARKET: COMPANY PROFILE

9.1 F. HOFFMANN-LA ROCHE AG

9.1.1 BUSINESS OVERVIEW

9.1.2 PRODUCT PORTFOLIO

9.1.3 KEY DEVELOPMENTS

9.1.4 CONTACT DETAILS

9.2 ABBOTT LABORATORIES

9.2.1 BUSINESS OVERVIEW

9.2.2 PRODUCT PORTFOLIO

9.2.3 KEY DEVELOPMENTS

9.2.4 CONTACT DETAILS

9.3 SIEMENS HEALTHCARE GMBH

9.3.1 BUSINESS OVERVIEW

9.3.2 PRODUCT PORTFOLIO

9.3.3 KEY DEVELOPMENTS

9.3.4 CONTACT DETAILS

9.4 AGILENT TECHNOLOGIES, INC

9.4.1 BUSINESS OVERVIEW

9.4.2 PRODUCT PORTFOLIO

9.4.3 KEY DEVELOPMENTS

9.4.4 CONTACT DETAILS

9.5 FLUIDIGM CORPORATION

9.5.1 BUSINESS OVERVIEW

9.5.2 PRODUCT PORTFOLIO

9.5.3 KEY DEVELOPMENTS

9.5.4 CONTACT DETAILS

9.6 BIO-RAD LABORATORIES, INC.

9.6.1 BUSINESS OVERVIEW

9.6.2 PRODUCT PORTFOLIO

9.6.3 KEY DEVELOPMENTS

9.6.4 CONTACT DETAILS

9.7 CEPHEID

9.7.1 BUSINESS OVERVIEW

9.7.2 PRODUCT PORTFOLIO

9.7.3 KEY DEVELOPMENTS

9.7.4 CONTACT DETAILS

9.8 RAINDANCE TECHNOLOGIES, INC

9.8.1 BUSINESS OVERVIEW

9.8.2 PRODUCT PORTFOLIO

9.8.3 KEY DEVELOPMENTS

9.8.4 CONTACT DETAILS

9.9 DOLOMITE CENTRE

9.9.1 BUSINESS OVERVIEW

9.9.2 PRODUCT PORTFOLIO

9.9.3 KEY DEVELOPMENTS

9.9.4 CONTACT DETAILS

9.10 MICRONIT MICROFLUIDICS

9.10.1 BUSINESS OVERVIEW

9.10.2 PRODUCT PORTFOLIO

9.10.3 KEY DEVELOPMENTS

9.10.4 CONTACT DETAILS

9.11 JOHNSON & JOHNSON

9.11.1 BUSINESS OVERVIEW

9.11.2 PRODUCT PORTFOLIO

9.11.3 KEY DEVELOPMENTS

9.11.4 CONTACT DETAILS

9.12 BECTON, DICKINSON AND COMPANY

9.12.1 BUSINESS OVERVIEW

9.12.2 PRODUCT PORTFOLIO

9.12.3 KEY DEVELOPMENTS

9.12.4 CONTACT DETAILS

List of Tables

List of Tables:

  • TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION
  • TABLE 2 IMPACT ANALYSIS OF DRIVERS ON OVERALL MARKET GROWTH
  • TABLE 3 IMPACT ANALYSIS OF RESTRAINTS ON OVERALL MARKET GROWTH
  • TABLE 4 CORPORATE AGREEMENTS
  • TABLE 5 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY, 2014-2024 (USD MILLION)
  • TABLE 6 GLOBAL MICROFLUIDIC DEVICES FOR IN-VITRO DIAGNOSTICS MARKET, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 7 GLOBAL MICROFLUIDIC DEVICES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2014-2027 (USD MILLION)
  • TABLE 8 GLOBAL PHARMACEUTICAL MICROFLUIDIC DEVICES MARKET, BY TYPE, 2014-2024 (USD MILLION)
  • TABLE 9 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY: MEDICAL DEVICES, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 10 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY: MEDICAL DEVICES MARKET, BY TYPE, 2014-2024 (USD MILLION)
  • TABLE 11 GLOBAL MICROFLUIDIC DEVICES MARKET, BY MATERIAL, 2014-2024 (USD MILLION)
  • TABLE 12 GLOBAL POLYMER MICROFLUIDIC DEVICES MARKET, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 13 GLOBAL GLASS MICROFLUIDIC DEVICES MARKET, BY REGION, 2014-2027 (USD MILLION)
  • TABLE 14 GLOBAL SILICON MICROFLUIDIC MARKET, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 15 GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2014-2024 (USD MILLION)
  • TABLE 16 GLOBAL MICROFLUIDIC DEVICES FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 17 GLOBAL MICROFLUIDIC DEVICES FOR CLINICAL AND VETERINARY DISGNOSTIC, BY REGION, 2014-2027 (USD MILLION)
  • TABLE 18 GLOBAL POINT OF CARE MICROFLUIDIC DEVICES MARKET, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 19 GLOBAL MICROFLUIDIC DEVICES: ANALYTICAL DEVICES, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 20 GLOBAL MICROFLUIDIC DEVICES FOR DRUG DELIVERY, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 21 GLOBAL MICROFLUIDIC DEVICES MARKET FOR ENVIRONMENTAL AND INDUSTRIAL APPLICATIONS, BY REGION, 2014-2024 (USD MILLION)
  • TABLE 22 GLOBAL MICROFLUIDIC DEVICES MARKET, BY REGION, 2014-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2014-2024 (USD MILLION)
  • TABLE 24 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY INDYSTRY, 2014-2024 (USD MILLION)
  • TABLE 25 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY MATERIAL, 2014-2024 (USD MILLION)
  • TABLE 26 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2014-2027 (USD MILLION)
  • TABLE 27 EUROPE MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2014-2024 (USD MILLION)
  • TABLE 28 EUROPE MICROFLUIDIC DEVICES MARKET, BY INDYSTRY, 2014-2024 (USD MILLION)
  • TABLE 29 EUROPE MICROFLUIDIC DEVICES MARKET, BY MATERIAL, 2014-2024 (USD MILLION)
  • TABLE 30 EUROPE MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2014-2027 (USD MILLION)
  • TABLE 31 ASIA MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2014-2024 (USD MILLION)
  • TABLE 32 ASIA MICROFLUIDIC DEVICES MARKET, BY INDYSTRY, 2014-2024 (USD MILLION)
  • TABLE 33 ASIA MICROFLUIDIC DEVICES MARKET, BY MATERIAL, 2014-2024 (USD MILLION)
  • TABLE 34 ASIA MICROFLUIDIC DEVICES MARKET, BY APPLICATION, 2014-2027 (USD MILLION)

List of Figures

List of Figures:

  • FIGURE 1 RESEARCH PROCESS
  • FIGURE 2 MARKET DYNAMICS
  • FIGURE 3 PORTERS FIVE FORCES MODEL
  • FIGURE 4 COMPETITIVE POSITIONING OF KEY COMPETITORS
  • FIGURE 6 GLOBAL MICROFLUIDIC DEVICES FOR IN-VITRO DISGNOSTICS, BY REGION, 2015 (%)
  • FIGURE 7 GLOBAL MICROFLUIDIC DEVICES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2015 (%)
  • FIGURE 8 GLOBAL PHARMACEUTICAL MICROFLUIDIC DEVICES MARKET, BY TYPE, 2015 (%)
  • FIGURE 9 GLOBAL MICROFLUIDIC DEVICES MARKET, BY INDUSTRY: MEDICAL DEVICES, BY REGION, 2015 (%)
  • FIGURE 10 GLOBAL MICROFLUIDIC MEDICAL DEVICES MARKET, BY TYPE, 2015 (%)
  • FIGURE 13 GLOBAL GLASS MICROFLUIDIC DEVICES MARKET, BY REGION, 2015 (%)
  • FIGURE 14 GLOBAL SILICON MICROFLUIDIC DEVICES MARKET, BY REGION, 2015 (%)
  • FIGURE 15 GLOBAL MICROFLUIDIC DEVICES MARKET, BY APPLICATION
  • FIGURE 16 GLOBAL MICROFLUIDIC DEVICES MARKET, BY REGION
  • FIGURE 17 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY COUNTRY (%)
  • FIGURE 18 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY INDUSTRY
  • FIGURE 19 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY MATERIAL
  • FIGURE 20 NORTH AMERICA MICROFLUIDIC DEVICES MARKET, BY APPLICATION
  • FIGURE 21 EUROPE MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 22 EUROPE MICROFLUIDIC DEVICES MARKET, BY INDUSTRY
  • FIGURE 23 EUROPE MICROFLUIDIC DEVICES MARKET, BY MATERIAL
  • FIGURE 24 EUROPE MICROFLUIDIC DEVICES MARKET, BY APPLICATION
  • FIGURE 25 ASIA MICROFLUIDIC DEVICES MARKET, BY COUNTRY, 2015 (%)
  • FIGURE 26 ASIA MICROFLUIDIC DEVICES MARKET, BY INDUSTRY
  • FIGURE 27 ASIA MICROFLUIDIC DEVICES MARKET, BY MATERIAL
  • FIGURE 28 ASIA MICROFLUIDIC DEVICES MARKET, BY APPLICATION